Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Amortization of Deferred Charges (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Amortization of Deferred Charges for 2 consecutive years, with $468000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Amortization of Deferred Charges fell 25.48% to $468000.0 in Q4 2025 year-over-year; TTM through Oct 2025 was $931000.0, a N/A change, with the full-year FY2025 number at $855000.0, down 22.13% from a year prior.
  • Amortization of Deferred Charges was $468000.0 for Q4 2025 at Kestra Medical Technologies, roughly flat from $469000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $989000.0 in Q2 2024 to a low of -$176000.0 in Q2 2025.